ArticleOncotarget2015

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

María Laura Polo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.